PVRIG(CD112R) Effector Reporter Cell
CBP74120
| I. Background | |
|
PVRIG（CD112R），是脊髓灰质炎病毒受体(PVR)家族的共抑制受体，在自然杀伤细 胞（NK）和 T 细胞上表达。它与其配体（CD112 或 PVRL2/nectin-2）结合，抑制 T 细胞和 NK 细胞对癌症的反应。因此，CD112R 作为一种新的免疫检查点抑制剂在癌症免疫治疗中 具有很高的潜力。 |
|
| II. Description | |
|
PVRIG(CD112R) Effector Reporter Cell 报告基因药靶模型很好的模拟了体内 PVRIG 的 信号转导过程，原理见下图所示。
 Figure 1. PVRIG(CD112R) Effector Reporter Cell |
|
| III. Introduction | |
| Expressed gene: |
PVRIG(CD112R) |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Synonym(s): | Poliovirus Receptor-related Immunoglobulin Domain-containing Protein, Transmembrane Protein PVRIG, 79270-1, 79270-2 |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: |
RPMI-1640+10%FBS+1 μg/ml Puromycin+800 μg/ml Hygromycin B
|
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Functional(Report Gene) Assay |
| IV. Representative Data | |
|
|
|
|
Figure 3. Dose Response of PVRIG Blocking Antibody in PVRIG(CD112R) Effector Reporter Cell (C7) with CD112 TCR Activator CHO (C1) |
|
